Therapy and Cytogenetic Complexity Shape the Mir-335/Sox4 Axis in Multiple Myeloma

Background Multiple myeloma (MM) is characterized by marked biological and genomic heterogeneity that may influence the activity of post-transcriptional regulatory networks. We previously identified SOX4 as a contributor to MM progression. Here, we investigated the functional activity of its post-transcriptional regulator miR-335 in primary patient-derived plasma cells and assessed whether disease stage, baseline SOX4 expression, and cytogenetic background influence miR-335 responsiveness. Methods Primary CD138 + plasma cells were isolated from bone marrow aspirates of 93 patients with MGUS/SMM (n = 11), newly diagnosed MM (ND-MM; n = 29), or treated MM (T-MM; n = 53). Each sample was divided into matched Sham-control and miR-335-transfected fractions. SOX4 modulation was evaluated by RT-qPCR and confirmed at protein level in representative samples. Responses were analyzed according to baseline SOX4 and CD56 expression, ploidy, and chromosome 1q status. miR-335 activity was independently assessed through SOX4/SPP1 concordance in 45 samples, while functional and morphological effects were evaluated in primary MM cultures. Results Baseline SOX4 expression increased with disease progression and was highest in T-MM. miR-335 significantly reduced SOX4 expression in T-MM, with the strongest response in samples with high baseline SOX4 expression (median miR-335/Sham ratio 0.47 versus 0.90 in SOX4-low T-MM; p < 0.01). SOX4 and SPP1 modulation were strongly concordant in the validation cohort (R²=0.74), while ACTB remained stable. Responsiveness was associated with CD56 expression and cytogenetic background: T-MM CD56-positive samples showed greater SOX4 suppression than CD56-negative samples, while euploid and chromosome 1q non-amplified T-MM cases were more responsive than their respective counterparts. miR-335 also reduced residual cell numbers in both ND-MM and T-MM cultures (p < 0.01). Notably, therapy-conditioned cells developed rosette-like multicellular aggregates following miR-335 exposure, suggesting a distinct adaptive phenotype associated with altered adhesion and microenvironment-related signaling. Conclusions miR-335 responsiveness in primary MM cells is shaped by disease stage, baseline SOX4 expression, cellular phenotype, and cytogenetic background. These findings identify a functionally responsive, therapy-conditioned MM subset and support a patient-stratified framework for investigating miR-335-based therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11139074/v1
Primary Topic
Multiple Myeloma Research and Treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Therapy and Cytogenetic Complexity Shape the Mir-335/Sox4 Axis in Multiple Myeloma

Barbara Montante, Elisabetta Lombardi, Chiara Cigana, Roberto Vettori et al.
Research Square
Multiple Myeloma Research and Treatments
preprint

Therapy and Cytogenetic Complexity Shape the Mir-335/Sox4 Axis in Multiple Myeloma

Barbara Montante, Elisabetta Lombardi, Chiara Cigana, Roberto Vettori, Rosanna Ciancia, Mario Mazzucato, Mariagrazia Michieli, Maurizio Zanetti, Marco Valvasori, Silvia Crestani, Francesco Agostini, Maurizio Rupolo, Kevin Rossi, Gonzalo Almanza, Riccardo Mezzetti, Joanna Dorota Barchanowska, Iris Scapinello, Matteo Valoppi
preprint en

Abstract

Background Multiple myeloma (MM) is characterized by marked biological and genomic heterogeneity that may influence the activity of post-transcriptional regulatory networks. We previously identified SOX4 as a contributor to MM progression. Here, we investigated the functional activity of its post-transcriptional regulator miR-335 in primary patient-derived plasma cells and assessed whether disease stage, baseline SOX4 expression, and cytogenetic background influence miR-335 responsiveness. Methods Primary CD138 + plasma cells were isolated from bone marrow aspirates of 93 patients with MGUS/SMM (n = 11), newly diagnosed MM (ND-MM; n = 29), or treated MM (T-MM; n = 53). Each sample was divided into matched Sham-control and miR-335-transfected fractions. SOX4 modulation was evaluated by RT-qPCR and confirmed at protein level in representative samples. Responses were analyzed according to baseline SOX4 and CD56 expression, ploidy, and chromosome 1q status. miR-335 activity was independently assessed through SOX4/SPP1 concordance in 45 samples, while functional and morphological effects were evaluated in primary MM cultures. Results Baseline SOX4 expression increased with disease progression and was highest in T-MM. miR-335 significantly reduced SOX4 expression in T-MM, with the strongest response in samples with high baseline SOX4 expression (median miR-335/Sham ratio 0.47 versus 0.90 in SOX4-low T-MM; p < 0.01). SOX4 and SPP1 modulation were strongly concordant in the validation cohort (R²=0.74), while ACTB remained stable. Responsiveness was associated with CD56 expression and cytogenetic background: T-MM CD56-positive samples showed greater SOX4 suppression than CD56-negative samples, while euploid and chromosome 1q non-amplified T-MM cases were more responsive than their respective counterparts. miR-335 also reduced residual cell numbers in both ND-MM and T-MM cultures (p < 0.01). Notably, therapy-conditioned cells developed rosette-like multicellular aggregates following miR-335 exposure, suggesting a distinct adaptive phenotype associated with altered adhesion and microenvironment-related signaling. Conclusions miR-335 responsiveness in primary MM cells is shaped by disease stage, baseline SOX4 expression, cellular phenotype, and cytogenetic background. These findings identify a functionally responsive, therapy-conditioned MM subset and support a patient-stratified framework for investigating miR-335-based therapeutic strategies.

Research Square
University of California San Diego (US), Centro di Riferimento Oncologico (IT), Moores Cancer Center (US)
Good health and well-being
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon